Gout
        
      Day 4 was a half day closeout to the EULAR 2023 Congress. For me the big presentations were the late breaking abstracts, although there were other review and abstract sessions for those remaining.  Many people missed the last day (June 3rd) of the meeting as a pending Milan airport strike on June 4th dictated last-minute changes to travel and learning. Here are a few of my favorite abstracts from the Late Breaker Session.
    
   
  Bella Mehta bella_mehta
            2 years 4 months ago 
          
         
          Depositions of crystals in coronary arteries were associated with MACE @rheumnow #EULAR2023 https://t.co/VHxtsB7ZsA
        
         
 
  Bella Mehta bella_mehta
            2 years 4 months ago 
          
         
          New treatment target for #gout 
#EULAR2023  
SEL-212 - 2 drugs one after the other! 
 - tolerogenic nanoparticles containing rapamycin followed by pegadricase
-only 50% reponded, but there were pts who didn't respond at all. 
@RheumNow https://t.co/RXK58piU85
        
         
 
  Janet Pope Janetbirdope
            2 years 4 months ago 
          
         
          Cool way to get peg uricase tolerated in #gout. ##Rapamycin nanoparticle Rx w SEL 212 a uricase -infusion reactions 3.4% - all premeds w steroids and antihistamines- some stomatitis - seemed to lower uric acid and have good tolerability LB0002 @RheumNow #EULAR2023 @eular_org https://t.co/xWzuY3Xkyw
        
         
 
  Dr. John Cush RheumNow
            2 years 4 months ago 
          
         
          Tune it at 1pm EST for RheumNow's daily #EULAR23 recaps.  You can find us live on Twitter, YouTube and LinkedIn. https://t.co/t531csjXo8
        
         
 
  Bella Mehta bella_mehta
            2 years 4 months ago 
          
         
          >= 2 tophi and carotid plaque by ultrasound could independently predict major adverse cardiovascular events in addition to conventional CVD risk factors in #gout, data from a single center cohort of 262 pts with 10 yr follow up #EULAR2023 @rheumnow abst#OP0154
        
         
  Bella Mehta bella_mehta
            2 years 4 months ago 
          
         
          Remember to discuss  bone density in your pts with #gout! Bone mineral density was significantly lower in pts with hyperuricemia, more so in males and elderly. Large cohort wirh 9017 pts from China! @EULAR2023 @rheumnow abst#AB1639 https://t.co/BGscJxMZno
        
         
 
  Bella Mehta bella_mehta
            2 years 4 months ago 
          
         
          Gut microbiome studies are implicated in all disease we study! 5 gut microbiota are suggested to have a causal relationship in #gout.
 68k controls and 2k gout pts.
Can experts comment if it's just data mining or discovery?  #EULAR2023 @rheumnow abst#ab1237 https://t.co/d1AkDPG8QR
        
         
        
      EULAR 2023 launched today to crowds of attendees.  The opening Plenary session and presidential address by Dr. Ian McInnes was followed by a number of overview and review sessions with but a half-day of abstracts presentations, on several therapeutic areas including osteoarthritis, JIA, COVID and more.  The following are a few of the presentations that caught my eye.
    
   
  Dr. Antoni Chan synovialjoints
            2 years 4 months ago 
          
         
          EULAR imaging recommendations in gout - ultrasound and DECT are recommended, double contour sign useful, by Peter Mandl, Abstr#0008 @RheumNow https://t.co/BNd1S3AJpB
        
         
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 Poster Hall
Poster Hall